Adults with sickle cell disease (SCD) who are started on buprenorphine to ease chronic pain — either in a…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Hydroxyurea, an approved medication to reduce the frequency of pain crises associated with sickle cell disease (SCD),…
An ongoing, early-phase clinical trial of pociredir, an oral small molecule being developed by Fulcrum Therapeutics as a possible…
Vascarta is launching a proof-of-concept Phase 1 clinical study to test its topical curcumin gel VAS-101 — which uses a…
People with sickle cell disease (SCD) who are hospitalized for opioid overdose have fewer serious complications than those without…
It may be possible to collect nearly three times as many stem cells for gene therapy for sickle cell…
The U.S. Food and Drug Administration has granted orphan drug status to Kind Pharmaceuticals’ investigational oral small molecule AND017 to…
Preschool-aged children with sickle cell disease (SCD) living in so-called food deserts, or areas where access to healthy food…
The number of stroke cases among adults and children with sickle cell disease (SCD) continues to increase in at…
Using lactated Ringer’s solution instead of normal saline to replace lost fluids in adults admitted to the hospital for…